Peripartum Cardiomyopathy: Risks Diagnosis and Management

References

• Bauersachs J, König T, van der Meer P, et al. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2019;21(7):827–843. doi:10.1002/ejhf.1493
   PubMed Web of Science ®Google Scholar
• Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000;283(9):1183–1188. doi:10.1001/jama.283.9.1183
   PubMed Web of Science ®Google Scholar
• Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12(8):767–778. doi:10.1093/eurjhf/hfq120
   PubMed Web of Science ®Google Scholar
• Gunderson EP, Croen LA, Chiang V, Yoshida CK, Walton D, Go AS. Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet Gynecol. 2011;118(3):583–591. doi:10.1097/AOG.0b013e318229e6de
   PubMed Web of Science ®Google Scholar
• Kolte D, Khera S, Aronow WS, et al. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc. 2014;3(3):e001056.
   PubMed Web of Science ®Google Scholar
• Mielniczuk LM, Williams K, Davis DR, et al. Frequency of peripartum cardiomyopathy. Am J Cardiol. 2006;97(12):1765–1768. doi:10.1016/j.amjcard.2006.01.039
   PubMed Web of Science ®Google Scholar
• Brar SS, Khan SS, Sandhu GK, et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol. 2007;100(2):302–304. doi:10.1016/j.amjcard.2007.02.092
   PubMed Web of Science ®Google Scholar
• Harper MA, Meyer RE, Berg CJ. Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortality. Obstet Gynecol. 2012;120(5):1013–1019. doi:10.1097/AOG.0b013e31826e46a1
   PubMed Web of Science ®Google Scholar
• Kao DP, Hsich E, Lindenfeld J. Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy. JACC Heart Fail. 2013;1(5):409–416. doi:10.1016/j.jchf.2013.04.011
   PubMed Web of Science ®Google Scholar
• Krishnamoorthy P, Garg J, Palaniswamy C, et al. Epidemiology and outcomes of peripartum cardiomyopathy in the United States: findings from the Nationwide Inpatient Sample. J Cardiovasc Med. 2016;17(10):756–761. doi:10.2459/JCM.0000000000000222
   Google Scholar
• Karaye KM, Ishaq NA, Sa’idu H, et al. Incidence, clinical characteristics, and risk factors of peripartum cardiomyopathy in Nigeria: results from the PEACE Registry. ESC Heart Fail. 2020;7(1):235–243.
   PubMed Web of Science ®Google Scholar
• Kamiya CA, Kitakaze M, Ishibashi-Ueda H, et al. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. Results from the Japanese Nationwide survey of peripartum cardiomyopathy. Circ J. 2011;75(8):1975–1981. doi:10.1253/circj.CJ-10-1214
   PubMed Web of Science ®Google Scholar
• Sliwa K, Petrie MC, van der Meer P, et al. Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry. Eur Heart J. 2020;41(39):3787–3797. doi:10.1093/eurheartj/ehaa455
   PubMed Web of Science ®Google Scholar
• Fett JD. Viral infection as a possible trigger for the development of peripartum cardiomyopathy. Int J Gynaecol Obstet. 2007;97(2):149–150. doi:10.1016/j.ijgo.2007.01.012
   PubMed Web of Science ®Google Scholar
• Fett JD, Ansari AA, Sundstrom JB, Combs GF. Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection. Int J Cardiol. 2002;86(2–3):311–316.
   PubMed Web of Science ®Google Scholar
• Ansari AA, Fett JD, Carraway RE, Mayne AE, Onlamoon N, Sundstrom JB. Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol. 2002;23(3):301–324. doi:10.1385/CRIAI:23:3:301
   PubMed Web of Science ®Google Scholar
• Lamparter S, Pankuweit S, Maisch B. Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol. 2007;118(1):14–20. doi:10.1016/j.ijcard.2006.04.090
   PubMed Web of Science ®Google Scholar
• Fett JD, Sundstrom BJ, Etta KM, Ansari AA. Mother-daughter peripartum cardiomyopathy. Int J Cardiol. 2002;86(2–3):331–332.
   PubMed Web of Science ®Google Scholar
• Pearl W. Familial occurrence of peripartum cardiomyopathy. Am Heart J. 1995;129(2):421–422. doi:10.1016/0002-8703(95)90032-2
   PubMed Web of Science ®Google Scholar
• van Spaendonck-Zwarts KY, Posafalvi A, van den Berg MP, et al. Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur Heart J. 2014;35(32):2165–2173. doi:10.1093/eurheartj/ehu050
   PubMed Web of Science ®Google Scholar
• Ware JS, Li J, Mazaika E, et al. Shared genetic predisposition in peripartum and dilated cardiomyopathies. N Engl J Med. 2016;374(3):233–241. doi:10.1056/NEJMoa1505517
   PubMed Web of Science ®Google Scholar
• Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U. Peripartum cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(2):207–221. doi:10.1016/j.jacc.2019.11.014
   PubMed Web of Science ®Google Scholar
• Goli R, Li J, Brandimarto J, et al. Genetic and phenotypic landscape of peripartum cardiomyopathy. Circulation. 2021;143(19):1852–1862. doi:10.1161/CIRCULATIONAHA.120.052395
   PubMed Web of Science ®Google Scholar
• Hilfiker-Kleiner D, Kaminski K, Podewski E, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007;128(3):589–600. doi:10.1016/j.cell.2006.12.036
   PubMed Web of Science ®Google Scholar
• Honigberg MC, Cantonwine DE, Thomas AM, Lim KH, Parry SI, McElrath TF. Analysis of changes in maternal circulating angiogenic factors throughout pregnancy for the prediction of preeclampsia. J Perinatol. 2016;36(3):172–177. doi:10.1038/jp.2015.170
   PubMed Web of Science ®Google Scholar
• Damp J, Givertz MM, Semigran M, et al. Relaxin-2 and soluble Flt1 levels in peripartum cardiomyopathy: results of the multicenter IPAC study. JACC Heart Fail. 2016;4(5):380–388. doi:10.1016/j.jchf.2016.01.004
   PubMed Web of Science ®Google Scholar
• Haghikia A, Kaya Z, Schwab J, et al. Evidence of autoantibodies against cardiac troponin I and sarcomeric myosin in peripartum cardiomyopathy. Basic Res Cardiol. 2015;110(6):60. doi:10.1007/s00395-015-0517-2
   PubMed Web of Science ®Google Scholar
• Liu J, Wang Y, Chen M, et al. The correlation between peripartum cardiomyopathy and autoantibodies against cardiovascular receptors. PLoS One. 2014;9(1):e86770. doi:10.1371/journal.pone.0086770
   PubMed Web of Science ®Google Scholar
• Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol. 2011;58(7):659–670. doi:10.1016/j.jacc.2011.03.047
   PubMed Web of Science ®Google Scholar
• Puri A, Sethi R, Singh B, et al. Peripartum cardiomyopathy presenting with ventricular tachycardia: a rare presentation. Indian Pacing Electrophysiol J. 2009;9(3):186–189.
   PubMedGoogle Scholar
• Carlson S, Gravely A, Adabag S. Trajectory of left ventricular ejection fraction among individuals eligible for implantable cardioverter-defibrillator. Pacing Clin Electrophysiol. 2021;44(5):800–806. doi:10.1111/pace.14168
   PubMed Web of Science ®Google Scholar
• McNamara DM, Elkayam U, Alharethi R, et al. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol. 2015;66(8):905–914. doi:10.1016/j.jacc.2015.06.1309
   PubMed Web of Science ®Google Scholar
• Irizarry OC, Levine LD, Lewey J, et al. Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and Non-African American Women. JAMA Cardiol. 2017;2(11):1256–1260. doi:10.1001/jamacardio.2017.3574
   PubMed Web of Science ®Google Scholar
• Sliwa K, Mebazaa A, Hilfiker-Kleiner D, et al. Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): eURObservational research programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM. Eur J Heart Fail. 2017;19(9):1131–1141. doi:10.1002/ejhf.780
   PubMed Web of Science ®Google Scholar
• Davis MB, Arendt K, Bello NA, et al. Team-based care of women with cardiovascular disease from pre-conception through pregnancy and postpartum. J Am Coll Cardiol. 2021;77(14):1763–1777. doi:10.1016/j.jacc.2021.02.033
   PubMed Web of Science ®Google Scholar
• Carland C, Panelli DM, Leonard SA, et al. Association of neighborhood income with clinical outcomes among pregnant patients with cardiac disease. Reprod Sci. 2022;29(10):3007–3014. doi:10.1007/s43032-022-00978-z
   PubMed Web of Science ®Google Scholar
• Olanipekun T, Abe T, Effoe V, et al. Racial and ethnic disparities in the trends and outcomes of cardiogenic shock complicating peripartum cardiomyopathy. JAMA Network Open. 2022;5(7):e2220937. doi:10.1001/jamanetworkopen.2022.20937
   PubMed Web of Science ®Google Scholar
• Ersbøll AS, Johansen M, Damm P, Rasmussen S, Vejlstrup NG, Gustafsson F. Peripartum cardiomyopathy in Denmark: a retrospective, population-based study of incidence, management and outcome. Eur J Heart Fail. 2017;19(12):1712–1720. doi:10.1002/ejhf.882
   PubMed Web of Science ®Google Scholar
• Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM. Pregnancy-related mortality in the United States, 2006–2010. Obstet Gynecol. 2015;125(1):5–12. doi:10.1097/AOG.0000000000000564
   PubMed Web of Science ®Google Scholar
• Ford ND, Cox S, Ko JY, et al. Hypertensive disorders in pregnancy and mortality at delivery hospitalization — United States, 2017–2019. MMWR Morb Mortal Wkly Rep. 2022;71(17):585–591. doi:10.15585/mmwr.mm7117a1
   PubMed Web of Science ®Google Scholar
• Bello N, Rendon ISH, Arany Z. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol. 2013;62(18):1715–1723. doi:10.1016/j.jacc.2013.08.717
   PubMed Web of Science ®Google Scholar
• Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J. 2006;152(3):509–513. doi:10.1016/j.ahj.2006.02.008
   PubMed Web of Science ®Google Scholar
• Goland S, Bitar F, Modi K, et al. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. J Card Fail. 2011;17(5):426–430. doi:10.1016/j.cardfail.2011.01.007
   PubMed Web of Science ®Google Scholar
• Forster O, Hilfiker-Kleiner D, Ansari AA, et al. Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail. 2008;10(9):861–868. doi:10.1016/j.ejheart.2008.07.005
   PubMed Web of Science ®Google Scholar
• Ekizler FA, Cay S. A novel marker of persistent left ventricular systolic dysfunction in patients with peripartum cardiomyopathy: monocyte count- to- HDL cholesterol ratio. BMC Cardiovasc Disord. 2019;19(1):114. doi:10.1186/s12872-019-1100-9
   PubMedGoogle Scholar
• Sanusi M, Momin ES, Mannan V, et al. Using echocardiography and biomarkers to determine prognosis in peripartum cardiomyopathy: a systematic review. Cureus. 2022;14(6):e26130. doi:10.7759/cureus.26130
   PubMed Web of Science ®Google Scholar
• Zagelbaum NK, Bhinder J, Gupta CA, Frishman WH, Aronow WS. Peripartum cardiomyopathy incidence, risk factors, diagnostic criteria, pathophysiology, and treatment options. Cardiol Rev. 2020;28(3):148–155.
   PubMed Web of Science ®Google Scholar
• Koziol KJ, Aronow WS, Giuliani E, Nunziata A. Peripartum cardiomyopathy: current understanding of pathophysiology, diagnostic workup, management, and outcomes. Curr Probl Cardiol. 2023;48(8):101716.
   PubMed Web of Science ®Google Scholar
• Morales A, Painter T, Li R, et al. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation. 2010;121(20):2176–2182. doi:10.1161/CIRCULATIONAHA.109.931220
   PubMed Web of Science ®Google Scholar
• Honigberg MC, Elkayam U, Rajagopalan N, et al. Electrocardiographic findings in peripartum cardiomyopathy. Clin Cardiol. 2019;42(5):524–529. doi:10.1002/clc.23171
   PubMed Web of Science ®Google Scholar
• Tibazarwa K, Lee G, Mayosi B, Carrington M, Stewart S, Sliwa K. The 12-lead ECG in peripartum cardiomyopathy. Cardiovasc J Afr. 2012;23(6):322–329. doi:10.5830/CVJA-2012-006
   PubMed Web of Science ®Google Scholar
• Arany Z, Elkayam U. Peripartum Cardiomyopathy. Circulation. 2016;133(14):1397–1409. doi:10.1161/CIRCULATIONAHA.115.020491
   PubMed Web of Science ®Google Scholar
• Bozkurt B, Colvin M, Cook J, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation. 2016;134(23):e579–e646. doi:10.1161/CIR.0000000000000455
   PubMed Web of Science ®Google Scholar
• Pierce T, Hovnanian M, Hedgire S, Ghoshhajra B. Imaging of cardiovascular disease in pregnancy and the peripartum period. Curr Treat Options Cardiovasc Med. 2017;19(12):94. doi:10.1007/s11936-017-0593-8
   PubMedGoogle Scholar
• Bauersachs J, Arrigo M, Hilfiker-Kleiner D, et al. Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2016;18(9):1096–1105. doi:10.1002/ejhf.586
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Bozkurt B, Aguilar D; Writing Committee Members, ACC/AHA Joint Committee Members. 2022 AHA/ACC/HFSA guideline for the management of heart failure. J Card Fail. 2022;28(5):e1–e167. doi:10.1016/j.cardfail.2022.02.010
   PubMedGoogle Scholar
• Bello NA, Bairey Merz CN, Brown H, et al. Diagnostic cardiovascular imaging and therapeutic strategies in pregnancy: JACC focus seminar 4/5. J Am Coll Cardiol. 2021;77(14):1813–1822. doi:10.1016/j.jacc.2021.01.056
   PubMed Web of Science ®Google Scholar
• Enriquez AD, Economy KE, Tedrow UB. Contemporary management of arrhythmias during pregnancy. Circ Arrhythm Electrophysiol. 2014;7(5):961–967. doi:10.1161/CIRCEP.114.001517
   PubMed Web of Science ®Google Scholar
• Halpern DG, Weinberg CR, Pinnelas R, Mehta-Lee S, Economy KE, Valente AM. Use of medication for cardiovascular disease during pregnancy. J Am Coll Cardiol. 2019;73(4):457–476. doi:10.1016/j.jacc.2018.10.075
   PubMed Web of Science ®Google Scholar
• Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165–3241. doi:10.1093/eurheartj/ehy340
   PubMed Web of Science ®Google Scholar
• Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol. 1991;78(1):128–135.
   PubMed Web of Science ®Google Scholar
• Shotan A, Widerhorn J, Hurst A, Elkayam U. Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med. 1994;96(5):451–456. doi:10.1016/0002-9343(94)90172-4
   PubMed Web of Science ®Google Scholar
• Stapel B, Kohlhaas M, Ricke-Hoch M, et al. Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy. Eur Heart J. 2017;38(5):349–361. doi:10.1093/eurheartj/ehw086
   PubMed Web of Science ®Google Scholar
• McNamara DM. Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy for Peripartum Cardiomyopathy (REBIRTH) [Internet]. clinicaltrials.gov; Report No.: NCT05180773; 2022. Available from: https://clinicaltrials.gov/ct2/show/NCT05180773. Accessed April 28, 2023.
   Google Scholar
• Sliwa K, Blauwet L, Tibazarwa K, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation. 2010;121(13):1465–1473. doi:10.1161/CIRCULATIONAHA.109.901496
   PubMed Web of Science ®Google Scholar
• Seghda TAA, Boro T, Bambara JE, et al. Prognosis of peripartum cardiomyopathy in sub-Saharan Africa (Burkina Faso South-West PPCM register). J Cardiol Cardiovasc Med. 2020;5(2):109–113. doi:10.29328/journal.jccm.1001096
   Google Scholar
• Haghikia A, Podewski E, Libhaber E, et al. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol. 2013;108(4):366. doi:10.1007/s00395-013-0366-9
   PubMed Web of Science ®Google Scholar
• Hilfiker-Kleiner D, Haghikia A, Berliner D, et al. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J. 2017;38(35):2671–2679. doi:10.1093/eurheartj/ehx355
   PubMed Web of Science ®Google Scholar
• Moiz B; Department of Pathology and Laboratory Medicine, the Aga Khan University Hospital, Karachi, Pakistan. A review of hemostasis in normal pregnancy and puerperium. Natl J Health Sci. 2017;2(3):123–127. doi:10.21089/njhs.23.0123
   Google Scholar
• Goland S, Modi K, Bitar F, et al. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail. 2009;15(8):645–650. doi:10.1016/j.cardfail.2009.03.008
   PubMed Web of Science ®Google Scholar
• Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Lippincott Williams & Wilkins; 2012:1728.
   Google Scholar
• Davis MB, Walsh MN. Cardio-Obstetrics. Circulation. 2019;12(2):e005417. doi:10.1161/CIRCOUTCOMES.118.005417
   PubMedGoogle Scholar
• Canobbio MM, Warnes CA, Aboulhosn J, et al. Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2017;135(8):e50–e87. doi:10.1161/CIR.0000000000000458
   PubMed Web of Science ®Google Scholar
• Koczo A, Marino A, Jeyabalan A, et al. Breastfeeding, cellular immune activation, and myocardial recovery in peripartum cardiomyopathy. JACC Basic Transl Sci. 2019;4(3):291–300. doi:10.1016/j.jacbts.2019.01.010
   PubMedGoogle Scholar
• Honigberg MC, Givertz MM. Peripartum cardiomyopathy. BMJ. 2019;30(364):k5287. doi:10.1136/bmj.k5287
   Web of Science ®Google Scholar
• Victora CG, Bahl R, Barros AJD, et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet. 2016;387(10017):475–490. doi:10.1016/S0140-6736(15)01024-7
   PubMed Web of Science ®Google Scholar
• Nguyen B, Jin K, Ding D, Remuzzi G. Breastfeeding and maternal cardiovascular risk factors and outcomes: a systematic review. PLoS One. 2017;12(11):e0187923. doi:10.1371/journal.pone.0187923
   PubMed Web of Science ®Google Scholar
• Jeejeebhoy FM, Zelop CM, Lipman S, et al. Cardiac arrest in pregnancy: a scientific statement from the American Heart Association. Circulation. 2015;132(18):1747–1773. doi:10.1161/CIR.0000000000000300
   PubMed Web of Science ®Google Scholar
• Honigberg MC, Givertz MM. Arrhythmias in peripartum cardiomyopathy. Card Electrophysiol Clin. 2015;7(2):309–317. doi:10.1016/j.ccep.2015.03.010
   PubMedGoogle Scholar
• Elkayam U, Goland S, Pieper PG, Silversides CK. High-risk cardiac disease in pregnancy: part II. J Am Coll Cardiol. 2016;68(5):502–516. doi:10.1016/j.jacc.2016.05.050
   PubMed Web of Science ®Google Scholar
• Olic JJ, Stöllberger C, Schukro C, et al. Usage of the wearable cardioverter-defibrillator during pregnancy. IJC Heart Vasc. 2022;1(41):101066. doi:10.1016/j.ijcha.2022.101066
   Google Scholar
• Lindley KJ, Bairey MCN, Davis MB, et al. Contraception and reproductive planning for women with cardiovascular disease. J Am Coll Cardiol. 2021;77(14):1823–1834. doi:10.1016/j.jacc.2021.02.025
   PubMed Web of Science ®Google Scholar
• Elkayam U, Tummala PP, Rao K, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med. 2001;344(21):1567–1571. doi:10.1056/NEJM200105243442101
   PubMed Web of Science ®Google Scholar
• Joseph MS, Davis MB. Counseling women with peripartum cardiomyopathy about subsequent pregnancies. Curr Treat Options Cardio Med. 2021;23(6):41. doi:10.1007/s11936-021-00915-4
   Web of Science ®Google Scholar
• Fett JD, Fristoe KL, Welsh SN. Risk of heart failure relapse in subsequent pregnancy among peripartum cardiomyopathy mothers. Int J Gynaecol Obstet. 2010;109(1):34–36. doi:10.1016/j.ijgo.2009.10.011
   PubMed Web of Science ®Google Scholar
• Barbosa MM, Freire CMV, Nascimento BR, et al. Rest left ventricular function and contractile reserve by dobutamine stress echocardiography in peripartum cardiomyopathy. Rev Port Cardiol. 2012;31(4):287–293. doi:10.1016/j.repc.2012.02.002
   PubMedGoogle Scholar
• Yucel E, Davis EF, Scott N, Lewis GD, DeFaria YD. Exercise ventricular reserve among women with a history of peripartum cardiomyopathy. JACC Case Rep. 2021;3(15):1649–1653.
   PubMedGoogle Scholar
• Davis MB, Rameez R, Joseph MS. Cardiac function in women with peripartum cardiomyopathy. JACC Case Rep. 2021;3(15):1654–1655. doi:10.1016/j.jaccas.2021.07.003
   PubMedGoogle Scholar
• Elkayam U. Risk of subsequent pregnancy in women with a history of peripartum cardiomyopathy. J Am Coll Cardiol. 2014;64(15):1629–1636. doi:10.1016/j.jacc.2014.07.961
   PubMed Web of Science ®Google Scholar